KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to 0.19%.

  • Adaptive Biotechnologies' Return on Capital Employed rose 2200.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.32% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Return on Capital Employed is 0.19%, which was up 2200.0% from 0.29% recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Return on Capital Employed high stood at 0.16% for Q1 2021, and its period low was 0.42% during Q2 2024.
  • Its 5-year average for Return on Capital Employed is 0.3%, with a median of 0.3% in 2022.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Return on Capital Employed crashed by -1500bps in 2024, and later soared by 2200bps in 2025.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Return on Capital Employed stood at 0.25% in 2021, then dropped by -6bps to 0.26% in 2022, then crashed by -43bps to 0.38% in 2023, then increased by 5bps to 0.36% in 2024, then skyrocketed by 47bps to 0.19% in 2025.
  • Its Return on Capital Employed was 0.19% in Q3 2025, compared to 0.29% in Q2 2025 and 0.33% in Q1 2025.